Gilead Sciences, Inc. (BIT:1GILD)
Italy · Delayed Price · Currency is EUR 108.22
+1.92 (1.81%)
At close: Jan 21, 2026
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of €136.96 billion as of January 22, 2026. Its market cap has increased by 22.66% in one year.
Market Cap
136.96B
Enterprise Value
149.24B
Revenue
24.79B
Ranking
n/a
PE Ratio
19.81
Stock Price
€108.22
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 194.48M to 136.96B, an increase of 70,322.81%. That is a compound annual growth rate of 21.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 131.27B | 1.21% |
| Dec 31, 2025 | 129.70B | 16.64% |
| Dec 31, 2024 | 111.19B | 21.76% |
| Dec 29, 2023 | 91.32B | -9.36% |
| Dec 30, 2022 | 100.75B | 25.80% |
| Dec 31, 2021 | 80.09B | 34.14% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 9.71B |
| DiaSorin | 4.01B |
| Amplifon | 2.95B |
| EL.En. | 1.12B |
| Philogen | 845.55M |
| Safilo Group | 798.65M |
| Pharmanutra | 613.65M |
| Garofalo Health Care | 484.94M |